title: Durable complete remission of therapy-refractory, tumor-stage cutaneous T-cell lymphoma under radioimmunotherapy with electron beam irradiation and denileukin diftitox.
authors.forename: Marion
authors.initials: M
authors.lastname: Wobser
authors.forename: Daniela
authors.initials: D
authors.lastname: Göppner
authors.forename: Sabrina C
authors.initials: SC
authors.lastname: Lang
authors.forename: Gabriele
authors.initials: G
authors.lastname: Beckmann
authors.forename: Michael
authors.initials: M
authors.lastname: Flentje
authors.forename: Selma
authors.initials: S
authors.lastname: Ugurel
authors.forename: Eva-B
authors.initials: EB
authors.lastname: Bröcker
authors.forename: Jürgen C
authors.initials: JC
authors.lastname: Becker
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004167:Diphtheria Toxin / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D005528:Foot; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012074:Remission Induction / Q000379:methods*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox